Target species
Pigs (sows and gilts).
Indications for use, specifying the target species
Reduction of the reproductive disorders caused by Porcine Reproductive and Respiratory Syndrome virus (European strain) in a contaminated environment: vaccination reduces the number of early farrowings and the number of still-births.
Contraindications
None
Special warnings for each target species
In PRRS infected herds, viral infection is heterogeneous and varies over time. In such context, the implementation of a vaccination program is a tool to improve the reproductive parameters and may contribute to the disease control in conjunction with sanitary measures.
Vaccinate healthy animals only.
Special precautions for use
Special precautions for use in animals
Apply usual procedures for the handling of animals.
Special precautions to be taken by the person administering the product to animals
To the user:
This product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Adverse reactions (frequency and seriousness)
Vaccination may induce a transient oedema (at most 3 cm) lasting generally less than one week and small local reaction (granulomas), without any effect on the health and the reproductive performance of the animal. Larger reactions (up to 7 cm diameter) have been observed occasionally after frequently repeated revaccinations. Vaccination may rarely cause hypersensitivity reactions. In such cases, an appropriate symptomatic treatment should be carried out.
Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation.
Interactions with other medicinal products and other forms of interaction
Data are available which demonstrate that this vaccine can be administered on a same day in a separate site, with inactivated vaccines against parvovirosis, influenza and Aujeszky’s disease as no adverse effect on the serological response has been observed. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other product therefore needs to be made on a case by case basis.
Amounts to be administered and administration route
One dose of 2 ml is administered by deep intramuscular route, in the neck muscles behind the ear, according to the following vaccination scheme:
Primary vaccination:
Gilts: 2 injections 3-4 weeks apart, at least 3 weeks before mating.
Sows: 2 injections 3-4 weeks apart (vaccination of all the sows of the herd within a short period is recommended).
Revaccination:
One injection at 60-70 days of each gestation, as of the first gestation following the primary vaccination.
Apply usual aseptic procedures. The use of a multi-dosing syringe is recommended.
Overdose (symptoms, emergency procedures, antidotes), if necessary
After administration of a double dose, no adverse reactions other than those described under Adverse reactions were observed.
Withdrawal period(s)
Zero days.